Iovance Biotherapeutics, Inc. (IOVA) — Dilution Risk Analysis

Current Snapshot

Iovance Biotherapeutics, Inc. (IOVA) has a DilutionWatch score of 45/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
452,971,432 Source
Public Float
387,983,792 Source
Float as % of Outstanding
85.7%

Dilution Risk Score

Score: 45/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 3 1, 4 9.

FormFiledAccession
3 2026-10-02 0001104659-26-113341
4 2026-10-02 0001104659-26-113342
4 2026-09-10 0001104659-26-106748
4 2026-09-10 0001104659-26-106750
4 2026-09-10 0001104659-26-106752
4 2026-09-03 0001104659-26-105099
4 2026-09-03 0001104659-26-105100
4 2026-09-03 0001104659-26-105101
4 2026-08-12 0001104659-26-095040
4 2026-08-10 0001104659-26-093482

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 9 months Source
Three-year share count growth 77.0% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 45/10) Source
Cash Runway
9 months Source
Share Count Growth (3-Year)
77.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.